bioAffinity Technologies (BIAF) Accounts Payables (2022 - 2025)
Historic Accounts Payables for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $940761.0.
- bioAffinity Technologies' Accounts Payables rose 2015.79% to $940761.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $940761.0, marking a year-over-year increase of 2015.79%. This contributed to the annual value of $987311.0 for FY2024, which is 6324.88% up from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' Accounts Payables is $940761.0, which was up 2015.79% from $1.2 million recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Accounts Payables ranged from a high of $1.4 million in Q1 2025 and a low of $146537.0 during Q1 2023
- In the last 4 years, bioAffinity Technologies' Accounts Payables had a median value of $782937.0 in 2024 and averaged $672505.0.
- As far as peak fluctuations go, bioAffinity Technologies' Accounts Payables surged by 45209.42% in 2023, and later plummeted by 537.46% in 2024.
- bioAffinity Technologies' Accounts Payables (Quarter) stood at $345042.0 in 2022, then surged by 75.28% to $604789.0 in 2023, then soared by 63.25% to $987311.0 in 2024, then dropped by 4.71% to $940761.0 in 2025.
- Its Accounts Payables was $940761.0 in Q3 2025, compared to $1.2 million in Q2 2025 and $1.4 million in Q1 2025.